2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO25] Mini-Oral Session 25　Translational Research / Clinical Pharmacology 4（Miscellaneous）
【E】

Fri. Feb 18, 2022 2:05 PM - 2:45 PM Room 8 (Sakura, 1F, Kyoto International Conference Center)

Chair：Chiyo K. Imamura（Advanced Cancer Translational Research Institute, Showa University），Yoshitsugu Horio（Department of Outpatient Services, Aichi Cancer Center Hospital）

[MO25-2] Phase I study of tiragolumab in combination with atezolizumab in Japanese patients with advanced solid tumors

○Noboru Yamamoto1, Takafumi Koyama3, Jun Sato3, Yoshida Tatsuya3, Kazuki Sudo3, Satoru Iwasa3, Shunsuke Kondo3, Kan Yonemori3, Toshio Shimizu3, Atsuko Kawasaki2, Kyoko Satake2, Shoyo Shibata2 (1.Department of Experimental Therapeutics, 2.Chugai Pharmaceutical Co., Ltd., 3.Department of Experimental Therapeutics, National Cancer Center Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password